Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Johnson & Johnson (

Johnson & Johnson Risks UK Lawsuit Over Talc Cancer Claim

UK claimants announced Wednesday legal action against US pharmaceutical and cosmetics giant Johnson & Johnson, alleging that women diagnosed with cancers were exposed to asbestos in the company's talcum powder.

International Business Times

Thousands of women plan legal action over alleged links between talc and cancer

If the action goes ahead it is understood to be the first of its kind against Johnson & Johnson in the UK.

Evening Standard

Are Wall Street Analysts Predicting Johnson & Johnson Stock Will Climb or Sink?

Johnson & Johnson has struggled to keep up with the broader market over the past year, and analysts are cautiously bullish on its future potential.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Highest-yielding Dividend Kings for Maximum Income and Stability

Looking for reliable yield? These three companies offer ever-increasing dividends and a lifetime of stability.

Barchart

Johnson & Johnson's Q3 2024 Earnings: What to Expect

Johnson & Johnson is all set to announce its third-quarter results this month, and analysts are projecting double-digit earnings decline.

Barchart

Johnson & Johnson Subsidiary Files For Bankruptcy For Third Time

Johnson & Johnson subsidiary files for bankruptcy to settle talc-related cancer lawsuits. Proposed billion settlement faces legal challenges.

Top News

How typography can make or break a brand

We speak to experts in the field of typography to learn how the right type can be the making of a brand — or its undoing.

Creative Bloq

Read news from The Economist, FT, and more,
with one subscription

3 Healthcare Stocks With Strong Buy Ratings

The healthcare sector is proving to be a robust investment haven, particularly as it continues to evolve with groundbreaking technology and strong government support. Therefore, adding strong A-rated stocks like Johnson & Johnson (JNJ), AbbVie (ABBV), and Merck & Co. (MRK) could help garner significant returns. Read more….

StockNews.com

'I'm on morphine patches every day': Woman still waiting for vaginal mesh removal four years later

‘I used to walk everywhere, but now I just potter around the house. I no longer walk to the shops,’ June Dunne tells Maya Oppenheim

The Independent UK

How High Can This Healthcare Stock Soar With Nvidia's Help?

Dividend King J&J can boost its MedTech business with Nvidia’s help.

Barchart

Women harmed by vaginal mesh in England get payout

The amount of the financial settlement has not been made public, although it is expected millions have been paid out

Evening Standard

This Dividend Aristocrat Just Had Its Best Day Ever After Earnings

This dividend aristocrat crushed Q2 earnings and issued strong guidance, and still has some fuel left in the tank for more growth.

Barchart

140 women win payouts for vaginal mesh complications

Women claimed the implants caused infection, bleeding, chronic pain, bladder and bowel perforations, and problems urinating

The Independent UK

140 women in England receive payout for vaginal mesh implant complications

Settlement from first successful group claim in England expected to total millions of pounds, but size of payments unknown

The Guardian - UK

Get all your
news in one place.

100's of premium titles.
One news app.

Salon

Big Pharma fought to keep prices high

Big Pharma exploited patent laws to stifle competition amid Medicare price negotiations, according to a new report

International Business Times UK

Once Valued At $21B, Avon Files For Bankruptcy Following Lawsuits For 'Cancer-causing' Products

Avon Products Inc. is declaring bankruptcy in the face of numerous lawsuits claiming that the talcum powder in its products causes cancer.

StockNews.com

3 Bargain Healthcare Stocks to Buy for Long-Term Gains

The healthcare sector is poised for significant growth, driven by advancements in drug development, ongoing research and development (R&D) efforts, and its ability to remain resilient even during economic downturns. Thus, investors might consider buying bargain pharma stocks: Johnson & Johnson (JNJ), Merck & Co. (MRK), and AbbVie (ABBV) for…

Barchart

Is It Time to Buy These Overlooked Dividend Stocks?

These defensive healthcare picks from the Dow Jones Industrial Average are worth a look at current levels for investors seeking passive income.

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

3 Top Stocks for Dividend Reinvestment Plans (DRIPs)

DRIPs offer a compelling strategy to boost investment returns. This approach helps to compound your gains over time by reinvesting dividends to buy more stock and reducing risk through dollar-cost investing. Top stocks, including Johnson & Johnson (JNJ), Coca-Cola (KO), and PepsiCo (PEP), are ideal for reinvesting dividends to maximize…

Barchart

Is Wall Street Bullish or Bearish on Johnson & Johnson Stock?

Despite Johnson & Johnson’s relative underperformance over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

StockNews.com

3 Healthcare Stocks Benefiting From an Aging Population

The healthcare industry is set for growth due to the growing demand for quality healthcare services and the aging population. Hence, quality healthcare stocks, such as Johnson & Johnson (JNJ), AbbVie (ABBV), and Merck & Co. (MRK), might be worth looking into. Read more….

StockNews.com

3 Pharmaceutical Stocks With Strong Pipelines

The pharmaceutical industry is flourishing due to increasing medical demands and rising healthcare spending worldwide. Hence, pharma stocks Eli Lilly (LLY), Johnson & Johnson (JNJ), and Merck & Co. (MRK), with strong pipelines, might be worth buying. Read more….

Kiplinger

Stock Market Today: Semis Get Slammed and Blue Chips Bounce

The potential for more curbs on tech sales to China set off a rotation into blue chips.

Barchart

Broader Market Slides as Chip Stocks Plunge

The S&P 500 Index ($SPX ) (SPY ) today is down -1.13%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.26%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.29%. Stock indexes today are mixed, with the Dow Jones Industrials posting a new record...

Barchart

Johnson & Johnson Earnings Preview: What to Expect

Johnson & Johnson is expected to release its second-quarter earnings next week, and analysts project a low single-digit profit dip.

1 … 7 8 9 10

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Dow Jones Industrial Average

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.